Regulus Therapeutics Inc (NASDAQ:RGLS)

21.13
Delayed Data
As of Mar 05
 +2.59 / +13.97%
Today’s Change
5.40
Today|||52-Week Range
25.60
+31.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-7.4M-17.4M-18.7M--
 
 
 
 
Depreciation911.0K1.0M1.4M--
 
 
 
 
Total Other Cash Flow1.2M5.1M6.0M--
 
 
 
 
Funds From Operations-5.3M-9.7M-11.3M--
 
 
 
 
Funds From/For Other Operating Expenses9.7M-983.0K17.0M--
 
 
 
 
Net Cash Flow - Operating Activities-15.1M-8.7M-28.3M--
 
 
 
 
 
InvestingIncrease In Investments-50.7M-62.0M-72.0M--
 
 
 
 
Decrease In Investments54.6M33.1M32.0M--
 
 
 
 
Capital Expenditures-467.0K-1.2M-800.0K--
 
 
 
 
Net Cash Flow Investing3.3M-30.4M-40.9M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.005.0M0.00--
 
 
Long Term Debt Reduction-412.0K-445.0K-100.0K--
 
 
 
 
Net Proceeds Stock Sale58.0K65.9M46.6M--
 
 
 
 
Common Preferred Redeemed--0.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing-354.0K70.5M46.5M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.00----
 
Net Change In Cash-12.1M31.4M-22.7M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account